Overactive Bladder
📧 Sign up to get email alerts when something new happens for Overactive Bladder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-04-20Clinical Trial Update: Investigation of Effects of Electrical Stimulation in Women With Vaginal Laxity [NA]
A clinical trial sponsored by Selcuk University is evaluating the effects of electrical stimulation for vaginal laxity, with Overactive Blad…
-
CLINICAL_TRIALS trial_result · 2025-04-18Clinical Trial Update: Efficacy of Animated Videos to Foster Healthy Bladder Behaviors in Community Women [NA]
A completed clinical trial assessed whether animated videos to encourage healthy bladder behaviors can improve outcomes in women with overac…
-
CLINICAL_TRIALS research · 2025-04-18Clinical Trial Update: Elastographic Assessment of Suburethral Tissue in Continent and Incontinent Women
A clinical trial is evaluating elastographic assessment of suburethral tissue in continent and incontinent women to explore tissue propertie…
-
CLINICAL_TRIALS trial_result · 2025-04-13Clinical Trial Update: Procedural Discomfort Related to Number of Intradetrusor Botox Injections [Phase 4]
Phase 4 trial evaluating whether increasing the number of intradetrusor Botox injections affects procedural discomfort for people with overa…
-
CLINICAL_TRIALS research · 2025-04-13Clinical Trial Update: Effect of Neuromodulation and Therapeutic Exercise in Urinary Incontinence [NA]
A clinical trial sponsored by Fundación Universidad Católica de Valencia San Vicente Mártir is evaluating neuromodulation plus therapeutic e…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
EMA approval · 2025-04-08EMA Authorised: Kentera (previously Oxybutynin Nicobrand) (oxybutynin) — Teva B.V.
The European Medicines Agency authorised Kentera, a transdermal oxybutynin patch by Teva B.V., for urinary incontinence associated with urge…
-
CLINICAL_TRIALS trial_result · 2025-04-06Clinical Trial Update: Effectiveness of Bilateral PTNS Compared to Unilateral PTNS for the Treatment of Overactive Bladder/Urge Incontinence [NA]
A clinical trial comparing bilateral versus unilateral percutaneous tibial nerve stimulation for overactive bladder and urge incontinence wa…
-
FDA approval · 2025-04-04FDA Approved: TROSPIUM CHLORIDE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved a supplemental application for trospium chloride from Glenmark Pharmaceuticals Inc., USA, granting a supplemental approval for …
-
CLINICAL_TRIALS research · 2025-04-03Clinical Trial Update: Testing MitoQ on Lower Urinary Tract Symptoms in Older Women With Metabolic Syndrome [Phase 2]
A Phase 2 clinical trial is evaluating the mitochondrial antioxidant MitoQ for lower urinary tract symptoms and overactive bladder in older …
-
CLINICAL_TRIALS trial_result · 2025-04-02Clinical Trial Update: Cycling Study With the Axonics System
Clinical trial update shows termination of a cycling study using the Axonics System for sacral neuromodulation in overactive bladder and uri…
-
FDA approval · 2025-04-02FDA Approved: FESOTERODINE FUMARATE — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' supplemental application for fesoterodine fumarate (ANDA 204792).
-
CLINICAL_TRIALS other · 2025-03-18Clinical Trial Update: Transvaginal Detrusor Nerve Radiofrequency Ablation for Treatment of Overactive Bladder [NA]
A clinical trial evaluating transvaginal detrusor nerve radiofrequency ablation for overactive bladder is currently enrolling by invitation.…
-
CLINICAL_TRIALS trial_result · 2025-03-06Clinical Trial Update: Minimizing Pain During Office Intradetrussor Botox Injection [Phase 4]
Phase 4 clinical trial update assessing methods to minimize pain during office intradetrusor Botox injections for overactive bladder; result…
-
EMA approval · 2025-03-04EMA Authorised: Toviaz (fesoterodine fumarate) — Pfizer Europe MA EEIG
The EMA authorised Toviaz (fesoterodine fumarate) for the treatment of overactive bladder, with Pfizer Europe MA EEIG as the marketing autho…
-
CLINICAL_TRIALS trial_result · 2025-02-26Clinical Trial Update: FREEOAB Study for Overactive Bladder [NA]
Clinical trial update for the FREEOAB study in overactive bladder, with results posted.
-
CLINICAL_TRIALS research · 2025-02-26Clinical Trial Update: NXT Post-Market Clinical Follow-up
This ClinicalTrials.gov update reports an ongoing post-market clinical follow-up for the NXT device from Laborie Medical Technologies Inc., …
-
CLINICAL_TRIALS trial_result · 2025-02-26Clinical Trial Update: Evaluation of the Tensi+ Device for the Treatment of Overactive Bladder
A clinical trial update indicates the study evaluating the Tensi+ device for overactive bladder has reached completion.
-
CLINICAL_TRIALS trial_result · 2025-02-19Clinical Trial Update: Comparing Treatments for Refractory Overactive Bladder: Bladder Denervation vs Botulinum Toxin Injections [Phase 4]
Phase 4 trial comparing bladder denervation to botulinum toxin injections for refractory overactive bladder has completed.
-
CLINICAL_TRIALS trial_result · 2025-02-19Clinical Trial Update: Association With Low Compliance Bladder in Women With LUTS
A completed clinical trial sponsored by National Taiwan University Hospital investigates association with low bladder compliance in women wi…
-
CLINICAL_TRIALS research · 2025-02-19Clinical Trial Update: Bladder Botox UTI Antibiotic Prophylaxis [Phase 4]
Phase 4 trial evaluating bladder botox (botulinum toxin A) for urinary tract infection prophylaxis in patients with overactive bladder or bl…
-
CLINICAL_TRIALS trial_result · 2025-02-14Clinical Trial Update: Intradetrusor Botulinum Toxin A for OAB Via 1 Versus 10 Injections: A Randomized Clinical Trial [Phase 4]
Phase 4 randomized trial comparing 1 versus 10 intradetrusor injections of botulinum toxin A for overactive bladder, evaluating efficacy and…
-
CLINICAL_TRIALS trial_result · 2025-02-10Clinical Trial Update: Comparisons of Phasic and Terminal DO
A completed clinical trial from National Taiwan University Hospital compares phasic and terminal detrusor overactivity in patients with over…
-
CLINICAL_TRIALS other · 2025-02-06Clinical Trial Update: Cefar URO - Symptomatic Treatment of Overactive Bladder [NA]
This clinical trial entry describes Cefar URO as a symptomatic treatment for overactive bladder, with the study status listed as not yet rec…
-
CLINICAL_TRIALS trial_result · 2025-02-03Clinical Trial Update: Efficacy and Tolerability of DITROPAN XL (Oxybutynin Chloride) Versus DETROL LA (Tolterodine Tartrate) in Treatment of Overactive Bladder [Phase 3]
Phase 3 trial comparing Ditropan XL (oxybutynin chloride) to Detrol LA (tolterodine tartrate) for overactive bladder, reporting efficacy and…
-
CLINICAL_TRIALS trial_result · 2025-02-03Clinical Trial Update: Lidocaine Patches Prior to Percutaneous Nerve Evaluation [Phase 2]
Phase 2 study evaluating lidocaine patches applied before percutaneous nerve evaluation in patients with overactive bladder, urge incontinen…